You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cellular Therapy

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type I Diabetes Trial in Pittsburgh (Ladarixin, Placebo)

Withdrawn
  • Type I Diabetes
  • Pittsburgh, Pennsylvania
    Institute of Cellular Therapeutics Allegheny Health Network
Jan 17, 2022

Huntington Disease Trial in Valinhos (Cellavita-HD)

Active, not recruiting
  • Huntington Disease
  • Cellavita-HD
  • Valinhos, São Paulo, Brazil
    Azidus Brasil Pesquisa Científica e Desenvolvimento Ltda.
Jun 22, 2021

Malignant Tumor, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Duarte

Recruiting
  • Malignant Neoplasm
  • +4 more
  • Chimeric Antigen Receptor T-Cell Therapy
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Malignant Tumors of Digestive Organs Trial in Hangzhou (gucy2c cart cells)

Recruiting
  • Malignant Neoplasms of Digestive Organs
  • gucy2c cart cells
  • Hangzhou, Zhejiang, China
    First affiliated hospital, Zhejiang University
Feb 26, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Active, not recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +11 more
  • Aldesleukin
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 13, 2022

ACB-IP 1.0 Convalescent Plasma in COVID-19 Infection

Recruiting
  • Covid19
    • Istanbul, Turkey
    • +1 more
    Feb 23, 2021

    Acute Respiratory Distress Syndrome, Covid19 Trial in Ottawa (Mesenchymal Stromal Cells)

    Completed
    • Acute Respiratory Distress Syndrome
    • Covid19
    • Mesenchymal Stromal Cells
    • Ottawa, Ontario, Canada
      The Ottawa Hospital
    Apr 23, 2021

    COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

    Active, not recruiting
    • COL6A3 Positive
    • +3 more
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Hepatocellular Carcinoma Trial in United States (AZD5851)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • AZD5851
    • Duarte, California
    • +9 more
    Oct 12, 2023

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL Trial in Seattle (biological,

    Recruiting
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +20 more
    • Chimeric Antigen Receptor T-Cell Therapy
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 11, 2022

    After Vaccination Against COVID-19 in Patients Treated With

    Recruiting
    • Kidney Failure, Chronic
    • +3 more
    • Immune response
    • Solicited common and expected adverse reactions shortly following vaccination (reactogenicity), use of antipyretic or pain medications and unsolicited adverse events and serious adverse events
    • Gdansk, Pomorskie, Poland
    • +3 more
    Feb 3, 2022

    Multiple Sclerosis Trial in Nantes (Cellular therapy with EBV specific autologous CTL infusion)

    Recruiting
    • Multiple Sclerosis
    • Cellular therapy with EBV specific autologous CTL infusion
    • Nantes, France
      University Hospital
    Jan 27, 2021

    Covid19, Acute Respiratory Distress Syndrome Trial in Canada (UC-MSCs, Placebo)

    Recruiting
    • Covid19
    • Acute Respiratory Distress Syndrome
    • UC-MSCs
    • Placebo
    • Oshawa, Ontario, Canada
    • +3 more
    May 4, 2021

    Diabetic Kidney Disease Trial in Ireland, Italy, United Kingdom (Mesenchymal Stromal Cells, Placebo)

    Recruiting
    • Diabetic Kidney Disease
    • Mesenchymal Stromal Cells
    • Placebo
    • Galway, Ireland
    • +3 more
    Jul 13, 2021

    Hair Disease Trial in Irvine (Intradermal Injection in hair loss, Platelet Rich Plasma, Adipose Derived Stem/Stromal Cells)

    Enrolling by invitation
    • Hair Disease
    • Intradermal Injection in hair loss
    • +7 more
    • Irvine, California
      Kenneth Williams, DO
    Aug 1, 2022

    Relapsed/Refractory Multiple Myeloma Trial in United States (genetic, biological, drug)

    Recruiting
    • Relapsed/Refractory Multiple Myeloma
    • ALLO-605
    • +3 more
    • Denver, Colorado
    • +3 more
    Feb 9, 2022

    Hepatocellular Carcinoma Trial in Beijing (adoptive immunotherapy, MWA)

    Completed
    • Hepatocellular Carcinoma
    • adoptive immunotherapy
    • MWA
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Mar 2, 2021

    B Cell Leukemia Trial in Seattle (Autologous CD19 CAR+ EGFTt + T cells)

    Active, not recruiting
    • B Cell Leukemia
    • Autologous CD19 CAR+ EGFTt + T cells
    • Seattle, Washington
      Seattle Children's Hospital
    Feb 15, 2022

    Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH

    Recruiting
    • Chronic Graft-versus-Host-Disease
    • +4 more
      • San Francisco, California
      • +15 more
      Jun 17, 2022

      COVID-19 Trial in Singapore (SARS-CoV-2 Specific T Cells)

      Recruiting
      • COVID-19
      • SARS-CoV-2 Specific T Cells
      • Singapore, Singapore
      • +4 more
      Jul 2, 2020

      Healthy Trial in United States (Filgrastim)

      Recruiting
      • Healthy
      • Duarte, California
      • +19 more
      Mar 7, 2022

      Peripheral T Cell Lymphoma (PTCL), Cell Therapy Trial in United States (MT-101, MT-101 + Conditioning (Lymphodepleting)

      Recruiting
      • Lymphoma, T-Cell, Peripheral
      • +4 more
      • MT-101
      • MT-101 + Conditioning (Lymphodepleting) Chemotherapy
      • Duarte, California
      • +8 more
      Jan 27, 2023

      Colorectal Adenocarcinoma, Metastatic Cholangiocarcinoma, Metastatic Colorectal Carcinoma Trial in Houston (biological, drug,

      Terminated
      • Colorectal Adenocarcinoma
      • +12 more
      • Adoptive Immunotherapy
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 28, 2020

      Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (CS1-CAR T Therapy, Cyclophosphamide, Fludarabine)

      Recruiting
      • Recurrent Plasma Cell Myeloma
      • Refractory Plasma Cell Myeloma
      • CS1-CAR T Therapy
      • +3 more
      • Duarte, California
        City of Hope Medical Center
      Nov 15, 2021

      CAR-T Cellular Therapy for B Cell Malignancies Involved in CNS

      Recruiting
      • Hematological Malignancy
      • CAR-T cells
      • Hangzhou, Zhejiang, China
      • +1 more
      Feb 26, 2020